The journey of adolescents with chronic disease to adult health care is fraught with challenges. Some of the challenges include difficulty engaging with adult services, medication adherence, and missed medical appointments, resulting in poor disease-specific and social outcomes. Reference Gray, Schaefer, Resmini-Rawlinson and Wagoner1 These challenges and poor outcomes have been associated with high health care costs. Reference Hepburn, Cohen, Bhawra, Weiser, Hayeems and Guttmann2
The key to improve the outcomes of youth with chronic neurological disease in adulthood is addressing the difference between transfer and transition of care. Transfer of care refers to the act of handing over the responsibility of medical care from one clinician to another clinician or clinical team. Transition, however, refers to the “purposeful and planned process that addresses the medical, psychosocial, and educational/vocational needs of adolescents/young adults with chronic conditions as they move from child-centered to adult-oriented health care systems”. Reference Gray, Schaefer, Resmini-Rawlinson and Wagoner1
Effective transition, in contrast to transfer, has been proposed to result in improved outcomes. Reference Campbell, Biggs and Aldiss3 Despite support for transition care being recognized as a global clinical and research priority by patients and families, there is a dearth of research and evidence-based procedures. Reference Castillo and Kitsos4 Recently, the Canadian Pediatric Society made a call to action with six recommendations to guide effective transition to adult care for youth with complex health needs. The six recommendations are: (1) ensuring transition care is continuous, comprehensive, coordinated, and developmentally appropriate, (2) employing a stepwise plan that increases autonomy and recognizes the changing parental/caregiver role during transition, (3) developing collaborative health care systems between pediatric and adult care across tertiary, community, and primary care settings, (4) redefining quality indicators according to youth perspectives, (5) implementing new educational initiatives to increase capacity to care for youth during transition, and (6) adapting program funding and payment models for physicians that are flexible to age cutoffs and shared care among pediatric and adult providers. Reference Toulany, Gorter and Harrison5
Among neurological disorders, there is a scarcity of published literature regarding transition care – although this topic has been addressed in recent times. Transition care is required in many neurological conditions including autoimmune encephalitis, epilepsy, functional disorders, headache, hydrocephalus, multiple sclerosis and demyelinating conditions, movement disorders, neuromuscular disorders, neuropathic pain, neurometabolic disorders, neuro-oncology, sleep, and stroke. A qualitative study in 2011 aimed to understand parental perceptions of the transfer process of their children with neurological diseases. This study highlighted a sense of loss, fear, and uncertainty as their child transferred to adult care. Reference Davies, Rennick and Majnemer6 The subspecialty of epilepsy, among the number of other neurological subspecialties, has clearly led the field of transition thus far. Published guidelines are now available and have addressed the transition of care for pediatric epilepsy patients to adult care not only in general but also for specific groups of complex epilepsies. Reference Andrade, Bassett and Bercovici7 The American Academy of Neurology (AAN) has also released a consensus statement outlining important considerations and proposed quality measures to assess outcomes of transition. Reference Brown, Camfield and Capers8
Although investigation into the outcomes and experience of youth with neurological diseases during transfer and transition are evolving, few specific and systematic initiatives exist to inform the process. A recent systematic review outlined initiatives in neurology including educational workshops for youth, multi-disciplinary clinics, mobile and web-based applications, and early start transition process. The focus of many of these interventions was developing self-management skills and orienting to adult services. Reference Preston, Green and Jindal-Snape9 These initiatives have focused mostly on meeting the needs of patients and families, with few initiatives addressing the needs of health care providers to improve transition. The lack of organized regional, provincial, and national processes are barriers to effective implementation of transition initiatives. Reference Calabrese, Lee and Mollica10
With the backdrop of the Canadian Pediatric Society call to action and AAN consensus statement, the pediatric and adult neurology divisions at the University of Toronto have committed to addressing the unmet needs of transition in neurology with formation of a working group. In this brief communication, we introduce the University of Toronto Pediatric-Adult Transition Working Group.
Our Pediatric-Adult Transition Working Group, established in 2021, is a collaborative interdivisional and inter-subspeciality group of faculty, advanced-practice providers, trainees, and patient-family advisors. The transition working group not only includes members from both adult and pediatric neurology care centers but also includes subspecialty representation from epilepsy, headache medicine, movement disorders, neuroinflammatory, neuromuscular, neurometabolics, neuromodulation, neuro-oncology, and stroke. In accordance with the recommendations of the Canadian Pediatric Society and AAN on transition care, the objectives of the working group are to: (1) deliver opportunities for education around transition planning into residency training and continuing medical education curriculums, (2) identify and address common barriers and facilitators for providing continuous, comprehensive, and coordinated transition care across neurological subspecialties, and (3) establish shared resources that can be used by patients, families, and healthcare providers across the field of neurology.
Taking these objectives into perspective, the group has undertaken initiatives to assess and educate on the topic of transition in neurology. Firstly, a survey (unpublished) was distributed in 2021 to assess faculty and resident perspectives. Less than 60% of faculty felt comfortable with the process of receiving and transferring patients from pediatric to adult care. Some reasons for discomfort included: (1) not knowing to whom or how to refer for adult care, (2) reviewing an overwhelming volume of clinical documentation during transfer of care, and (3) not knowing how to empower young adults to self-manage their disease. The results of this preliminary survey highlighted that a coordinated communication between pediatric and adult providers is required in the current landscape of transition care at our centers.
Another initiative of the transition working group was hosting two symposia on transition in 2021 and 2022 (Table 1 details the topics in the two symposia). The symposia were a platform for co-learning among academic and community neurologists, trainees, local transition experts from non-neurological subspecialties, international keynote speakers, and people with lived experience. The transition symposia were advertised broadly, and members of the Canadian Neurological Society, the Canadian Association of Child Neurology, and the Canadian Society of Clinical Neurophysiology were invited to participate. The symposia were integrated as part of residency academic half day for pediatric and adult neurology residents and regarded as required learning in anticipation of their future careers. Continuing medical education credits were available for practicing healthcare providers. Common discussions across sessions at the symposia included: “When is my patient ready to go to adult care?,” “Who should provide their care next?,” “When am I [patient] ready to move to adult care?,” “What documentation should I send the adult provider,?” “How often should I see my patient in the adult clinic?,” “Who do I [patient] talk to if I have a problem before my first appointment in the adult clinic?,” and “How do we manage drug coverage while in adult care?.” Although needs of patients are individualistic, these discussions at the symposia highlighted a role for shared resources across subspecialties to support transition such as transition readiness assessments, drug coverage navigation information, and referral templates.
In response to the initial ideas gathered from the informal survey and the symposia, the transition working group has outlined several deliverables over the next three years. First, the transition working group is collaborating with Program Directors of the pediatric and adult neurology residency training programs to integrate education and increase awareness about transition into the educational curriculum. This will be done by implementing and embedding teaching objectives on subspecialty rotations about how to carry out transition of a patient to adult care and future hands-on learning opportunities for residents in dedicated transition clinics. We aim to align these objectives with the entrustable professional activities (EPAs) as part of competency-based medical education.
Second, the working group will develop and distribute a database of all physicians in Toronto and the Greater Toronto Area who have expertise, interest, and interdisciplinary resources to care for transitioning patients.
Third, the transition working group will compile a guide for best practices for program funding and compensation models in shared pediatric and adult transition clinics.
Lastly, the working group is collaborating with patient and family advisors to create a centralized, accessible, and relevant online resource for patients, families, and providers to support transition to adult neurological care.
The University of Toronto Divisions of Pediatric and Adult Neurology have recognized transition as a critical area for research and program development. As this is a national issue, our Pediatric-Adult Transition Working Group invites providers, patients, families, and other university neurology programs and specialties from across Canada to collaborate and share ideas for ongoing projects and future work. The working group envisions that our combined efforts will result in a national neurology transition strategy that will leverage resources and health policy changes. We are excited for the future of transition care for chronic neurological diseases and hope that feelings of fear and uncertainty will be replaced by feelings of reassurance, safety, and empowerment in patients, families, and providers as they embark on crossing the bridge from pediatric to adult neurological care.
Acknowledgments
We would like to acknowledge the collaboration and efforts of all University of Toronto Pediatric-Adult Transition Working Group members (in alphabetical order): Danielle Andrade, Hernan Gonorazky, Jennifer Hyde, Carolina Gorodetsky, Hans Katzberg, Jeff Kobayashi, Marissa Lagman, Mary-Jane Lim Fat, Mahendranath Moharir, Katherine Sawicka, Catherine Shao, Elizabeth Slow, Ingrid Tein, Lindsey Vogt, Kathryn Yang, Ivanna Yau, and Winnie Yau.
Author contribution
All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, writing, and revision of the manuscript.
KMS contributed intellectual input and led manuscript writing and revisions.
LV contributed intellectual input, designed tables, and contributed to manuscript writing and revisions.
DMA, HDK, SPM, MM, DFTW, and AMLB contributed intellectual input and to manuscript writing and revision.
Funding
None.
Competing interests
KMS reports doctoral scholarships from the Canadian Institutes of Health Research and The Hospital for SickChildren Clinician Scientist Training Program.
LMV reports no disclosures.
DMA reports no disclosures.
HDK reports consulting fees and advisory board participation from CSL Behring, Octapharma, Alexion, UCB, ArgenX, Merz, and Dianthus, payment for speaking from CSL Behring and Alexion, participation in the Data Safety Monitoring Boards of Alexion, UCB, and Abcuro, and grants from CIHR, Takaeda, and ArgenX.
SPM reports payment from various legal firms for expert opinion and testimony related, to neonatal brain injury, unpaid board membership of the BC Children’s Hospital Foundation, and grant funding from CIHR, the Ontario Brain Institute, National Institutes of Health, and the Cerebral Palsy Alliance.
MM reports no disclosures.
DFT reports Medical advisory as a board member for Hydrocephalus Canada.
AML reports receiving royalties as author from Canadian Pharmacists Association, participating in advisory boards for TEVA, Lundbeck, Pfizer, and Miravo, research and unrestricted educational grants submitted to Hospital for Sick Children and Center for Headache, Women’s College Hospital.